共 50 条
Real-world healthcare costs and resource utilization (HRU) among patients treated with erenumab in the United States: A retrospective claims database study
被引:0
|作者:
Tepper, S. J.
[1
]
Schwedt, T. J.
[2
]
Vo, P.
[3
]
Joshi, P.
[4
]
Glassberg, M.
[5
]
Abdrabboh, A.
[5
]
Ferraris, M.
[3
]
Tiwari, S.
[4
]
Thompson, J.
[6
]
机构:
[1] Dartmouth Hitchcock Dept Neurol, Geisel Sch Med, Hanover, NH USA
[2] Mayo Clin, Phoenix, AZ USA
[3] Novartis Pharma AG, Basel, Switzerland
[4] Novartis Healthcare Private Ltd, Value & Access, Hyderabad, Telangana, India
[5] Novartis Pharmaceut, E Hanover, NJ USA
[6] Kantar Hlth, New York, NY USA
来源:
关键词:
D O I:
暂无
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
AL050
引用
下载
收藏
页码:17 / 18
页数:2
相关论文